FDA approves AbbVie’s hepatitis treatment

AbbVie’s new multidrug regimen for hepatitis C was approved by the Food and Drug Administration.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.